Quality service is fundamental.
Release time:
2020-07-22
Quality Service is Fundamental
Group Company 2018 Outstanding Salesman Peak Pharmacy Xinhua Pharmacy Wang Xiuling
2018 Xinhua Pharmacy successfully completed the task targets issued by the company at the beginning of the year with the joint efforts of all employees. The main work is:
precise positioning, characteristic management. Xinhua Pharmacy has cooperated with major foreign companies after two years of exploration and gradually formed a DTP pharmacy model. We have the most advanced Roche cold chain sales system. Because of this, I have obtained many new and special drugs. In addition, my service attitude has been recognized by many doctors. After hard work, cancer patients in the oncology departments of major hospitals have bought medicines in our pharmacies, which has further expanded the popularity of Xinhua Pharmacy. Now Xinhua Pharmacy has begun to transform from traditional sales to new retail, which is a new model for pharmacy development in the new era.
Catch up in adversity. At the end of the first quarter of last year, the performance of our store was very unsatisfactory and the atmosphere of the whole store was very poor. Internally, I took two team members to carry out group building, made some communication, and the atmosphere improved somewhat. I actively expanded my business abroad. Under various immature conditions, I drove to the big hospital in Jinliqu area to deliver medicine by myself, basically on call. My efforts have been recognized by doctors in various regions and have established good cooperative relations with them. I remember a department director of the Oncology Department of Dongyang People's Hospital. He was very rigorous. He once delivered medicine and arrived half an hour earlier. He said why you did things so freely. Since then, in hot weather, I have waited until the right time. He appeared at the door of his office and never arrived late or early. In the end, our work was highly recognized by him. Sometimes in order to facilitate patients, drugs are sent directly to patients' homes. In order to improve efficiency, actively communicate with patients and try to send them together. Sometimes I have to send seven or eight patients a day, and I often have to eat at one or two o'clock. There are no weekends, no holidays, and the Dragon Boat Festival also delivers medicine in Dongyang. I just want to do more and work hard to complete the task.
comprehensively improve service, devote to serving various suppliers and doctors, and assume the role of intermediate bridge. As long as the supplier has a demand, I will respond to any request. If the doctor has any questions, I will answer them. In order to facilitate the doctor to find me, I also bought another mobile phone to apply for the short number of the health network. This small measure not only strengthened the contact with the doctor, but also communicated and solved the problem in time. This year, the serious illness medical insurance policy has been constantly changing. I went to the Municipal Medical Insurance Bureau many times to communicate, get the latest news and reimbursement process, and take the trouble to communicate with doctors and suppliers, so that the medical insurance policy can be communicated to patients in time, so that more patients can benefit in time. If the doctor has something unclear, I will ask the doctor to let the patient come to me. I will give directions one by one. The patient will run less and complain less. Before, there were 5 designated pharmacies outside Jinhua city. under my service, many non-designated patients also bought drugs directly in our store. For example, the original designated pharmacy for external distribution in Jinhua Hospital of Traditional Chinese Medicine was another pharmacy. Due to my service and professional ability, I was recognized by doctors and the director of the Medical Insurance Office, and the connection between the Hospital of Traditional Chinese Medicine and our pharmacy was opened in 2018 5 . So far, we have basically distributed the drugs for serious diseases in the whole hospital of traditional Chinese medicine.
Do a good job of extending services, doing sales while doing popularity and popularity. In order to increase the visibility of the pharmacy, we have cooperated with various foundations to provide free drug donation services to patients in Jinliqu area. In addition to the drugs normally purchased for many serious diseases, various foundations also provide "buy and give" activities. This service is free of charge, and a special licensed pharmacist is responsible for this work. At that time, in line with the mentality of not making money and earning popularity, I took over the service of drug donation. Now there are more and more varieties of drug donation, and more and more foundations cooperate with us, such as the China Women's Development Foundation, China Cancer Foundation, China Primary Health Care Foundation, etc. have established cooperation with us. Although there are many trivial things, in addition to winning popularity, the sales performance and popularity of our stores are also improving. Besides Jinhua local people, there are also people from surrounding counties and cities, as well as Lishui, Quzhou, Jiangshan and other places. Our ultimate goal is: no matter manufacturers, patients or doctors in Jinliqu area, when new special drug products are needed, the first thing we can think of is Xinhua Pharmacy, our peak pharmacy.
Relocation is not closed. This year, Xinhua Pharmacy completed the overall relocation work. In order to have a good transition process and reduce the losses caused by the relocation of the hospital, the company leaders decided to move Xinhua Pharmacy to its original store opposite in the first half of this year. In order to successfully complete the relocation work, we have done a good job of communication with hospitals, salesmen and patients in advance, which has been recognized by everyone. At the same time, in order not to affect the sales performance, the whole store staff began to work overtime. From the beginning to the end, the store was not closed for a day. Everyone in the store was too busy to keep up their waist, but the atmosphere of the whole store was very good, and everyone worked very hard.
pharmacies should achieve good performance. In addition to professional requirements, high-quality service is fundamental. I have always practiced this point and made continuous efforts at the same time. Because of this, the performance of Xinhua Pharmacy has also been booming in recent years, and I have also used this platform to get great promotion and countless honors. (According to Wang Xiuling's speech at the summary and commendation meeting of the group company)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page